InventisBio (SH:688382) Zheng Quan Zhi Xing·2025-05-30 11:54Summary of Key Points Core Viewpoint The announcement details the changes in the governance structure of Yifang Biotechnology (Shanghai) Co., Ltd., including the cancellation of the supervisory board, changes in registered capital, and amendments to the company's articles of association and internal governance systems. Group 1: Changes in Registered Capital - The total share capital of the company increased to RMB 578,327,844 following the completion of the stock registration for the second vesting period of the restricted stock incentive plan on March 24, 2025 [1][2] - The board of directors authorized relevant personnel to handle the business registration changes without needing to submit the matter to the shareholders' meeting [2] Group 2: Cancellation of Supervisory Board - The company will no longer have a supervisory board, and its functions will be transferred to the audit committee of the board of directors [2][3] - Relevant internal rules related to the supervisory board will be abolished [2] Group 3: Amendments to Articles of Association and Governance Systems - The articles of association will be revised to align with the current laws and regulations, including the Company Law and the Guidelines for Articles of Association of Listed Companies [2][4] - Internal governance systems, including rules for shareholders' meetings, board meetings, and various committees, will be amended, with some requiring approval from the shareholders' meeting [2][3]